BBWI · Bath & Body Works, Inc. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · BBWI

1Y 3Y 5Y Max

Annual Quarterly

Income Statement

Line item	FY 2025	FY 2026	FY 2024	FY 2023	FY 2022	FY 2021
Revenue	$7.29B	$7.29B◇	$7.31B	$7.43B	$7.56B	$7.88B
Cost of Revenue	$4.10B	-	$4.07B	$4.19B	$4.30B	$4.03B
Gross Profit	$3.19B	$3.19B◇	$3.23B	$3.24B	$3.25B	$3.85B
R&D	-	-	-	-	-	-
SG&A	$2.06B	$2.06B◇	$1.97B	$1.95B	$1.88B	$1.85B
Total Operating Expenses	-	-	-	-	-	-
D&A	$254.00M	-	$282.00M	$269.00M	$221.00M	$363.00M
Operating Income	$1.13B	$1.13B◇	$1.27B	$1.28B	$1.38B	$2.01B
Interest Expense	$276.00M	$276.00M◇	$312.00M	$345.00M	$348.00M	$388.00M
Income Tax	$233.00M	$233.00M◇	$230.00M	$143.00M	$251.00M	$348.00M
Net Income	$649.00M	$649.00M◇	$798.00M	$878.00M	$800.00M	$1.33B
EPS - Basic	$3.12	$3.12◇	$3.62	$3.86	$3.45	$4.96
EPS - Diluted	$3.11	$3.11◇	$3.61	$3.84	$3.43	$4.88

Balance Sheet

Line item	FY 2025	FY 2026	FY 2024	FY 2023	FY 2022	FY 2021
Cash & Equivalents	$953.00M	$953.00M◇	$674.00M	$1.08B	$1.23B	$1.98B
Accounts Receivable	$180.00M	-	$205.00M	$224.00M	$226.00M	$240.00M
Inventory	$699.00M	-	$734.00M	$710.00M	$709.00M	$709.00M
Accounts Payable	$465.00M	-	$338.00M	$380.00M	$455.00M	$435.00M
Current Assets	$2.02B	$2.02B◇	$1.82B	$2.12B	$2.27B	$3.01B
Total Assets	$5.07B	$5.07B◇	$4.87B	$5.46B	$5.49B	$6.03B
Current Liabilities	$1.59B	$1.59B◇	$1.23B	$1.29B	$1.38B	$1.29B
Long-term Debt	$3.61B	$3.61B◇	$3.88B	$4.39B	$4.86B	$4.85B
Total Liabilities	-	-	-	-	-	-
Stockholders' Equity	($1.28B)	($1.28B)◇	($1.39B)	($1.63B)	($2.21B)	($1.52B)
Retained Earnings	($1.44B)	-	($1.58B)	($1.84B)	($2.40B)	($1.80B)

Cash Flow

Line item	FY 2025	FY 2026	FY 2024	FY 2023	FY 2022	FY 2021
Operating Cash Flow	$1.10B	$1.10B◇	$886.00M	$954.00M	$1.14B	$1.49B
Investing Cash Flow	($227.00M)	($227.00M)◇	($162.00M)	($286.00M)	($328.00M)	($259.00M)
Financing Cash Flow	($599.00M)	($599.00M)◇	($1.13B)	($815.00M)	($1.56B)	($3.19B)
CapEx	$237.00M	$237.00M◇	$226.00M	$298.00M	$328.00M	$270.00M
Free Cash Flow	$865.00M	$865.00M◇	$660.00M	$656.00M	$816.00M	$1.22B

Ratios

Metric	FY 2025	FY 2026	FY 2024	FY 2023	FY 2022	FY 2021
Profitability
Gross margin	43.7%	43.7%	44.3%	43.6%	43.1%	48.9%
Operating margin	15.4%	15.4%	17.3%	17.3%	18.2%	25.5%
EBITDA margin	18.9%	-	21.2%	20.9%	21.1%	30.1%
Net margin	8.9%	8.9%	10.9%	11.8%	10.6%	16.9%
Free cash flow margin	11.9%	11.9%	9.0%	8.8%	10.8%	15.5%
FCF / Net income	1.33	1.33	0.83	0.75	1.02	0.92
R&D / Revenue	-	-	-	-	-	-
SG&A / Revenue	28.3%	28.3%	26.9%	26.3%	24.9%	23.4%
Effective tax rate	26.4%	26.4%	22.4%	14.0%	23.9%	20.7%
Return on assets	12.8%	12.8%	16.4%	16.1%	14.6%	22.1%
Return on equity	-50.7%	-50.7%	-57.6%	-54.0%	-36.3%	-87.8%
Return on invested capital	35.5%	35.5%	39.3%	40.0%	39.4%	47.8%
Liquidity
Current ratio	1.27	1.27	1.48	1.64	1.64	2.33
Quick ratio	0.83	1.27	0.88	1.09	1.13	1.78
Cash ratio	0.60	0.60	0.55	0.84	0.89	1.53
Leverage
Debt / Equity	-2.82	-2.82	-2.80	-2.70	-2.20	-3.20
Debt / Assets	0.71	0.71	0.80	0.80	0.88	0.81
Debt / EBITDA	2.62	-	2.51	2.82	3.04	2.05
Interest coverage	4.1x	4.1x	4.1x	3.7x	4.0x	5.2x
Equity multiplier	-3.96	-3.96	-3.52	-3.36	-2.49	-3.97
Liabilities / Assets	-	-	-	-	-	-
Efficiency
Asset turnover	1.44	1.44	1.50	1.36	1.38	1.31
Inventory turnover	5.87	-	5.55	5.91	6.07	5.68
Days sales outstanding	9d	-	10d	11d	11d	11d
Days inventory outstanding	62d	-	66d	62d	60d	64d
Days payable outstanding	41d	-	30d	33d	39d	39d
Cash conversion cycle	30d	-	46d	40d	32d	36d
Valuation
P / E	7.0x	7.0x	10.4x	11.3x	13.0x	11.2x
P / B	-	-	-	-	-	-
P / S	0.6x	-	1.1x	1.3x	1.4x	1.9x
EV / EBITDA	5.2x	-	7.4x	8.5x	8.8x	7.5x
Growth
Revenue growth (YoY)	-0.2%	0.0%	-1.6%	-1.7%	-4.1%	-37.6%
Revenue CAGR (3y)	-1.2%	-0.6%	-2.5%	-16.2%	-	-15.9%
Revenue CAGR (5y)	-10.4%	-1.5%	-	-10.9%	-9.8%	-8.9%
Gross profit growth (YoY)	-1.4%	0.0%	-0.1%	-0.6%	-15.6%	-17.4%
Operating income growth (YoY)	-11.1%	0.0%	-1.5%	-6.6%	-31.5%	27.2%
Net income growth (YoY)	-18.7%	0.0%	-9.1%	9.8%	-40.0%	57.9%
EPS growth (YoY)	-13.9%	0.0%	-6.0%	12.0%	-29.7%	62.7%
EPS CAGR (3y)	-3.2%	-6.8%	-9.6%	8.6%	-	28.3%
EPS CAGR (5y)	0.7%	-8.6%	-	10.7%	0.1%	4.2%
FCF growth (YoY)	31.1%	0.0%	0.6%	-19.6%	-33.2%	-32.5%
FCF CAGR (5y)	-13.7%	-6.7%	-	-2.6%	3.1%	6.3%
Book value growth (YoY)	7.5%	0.0%	14.9%	26.2%	-45.3%	-129.3%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2026-01-31.

Business segments

$7.29B total

Reportable Segment$7.29B · 100.0%

Geographic

$707.00M total

International$707.00M · 100.0%

Stability scores

Piotroski F-score

FY 2025 · 9-point quality

5/9

Neutral

✓Net income positive
✓Operating cash flow positive
✗ROA improved YoY
✓Cash flow > net income
✓Long-term debt decreased
✗Current ratio improved
✓No share dilution
✗Gross margin improved
✗Asset turnover improved

Peer comparison

Same SIC group: Retail-Retail Stores, NEC

Company	Revenue (last FY)	Net margin	ROE
RENT	$329.80M	6.9%	-62.6%
WOOF	$5.96B	0.2%	0.8%
BARK	$484.18M	-6.8%	-33.0%
FLWS	$1.69B	-11.9%	-74.5%
LESL	$1.24B	-19.1%	58.1%

Comparing Bath & Body Works against the 5 most active filers in the same SIC group.

Dividends

$0.80/share trailing 12 months · 0.0% YoY

Ex-date	Per share
Feb 20, 2026	$0.2000
Nov 21, 2025	$0.2000
Aug 22, 2025	$0.2000
Jun 6, 2025	$0.2000
Feb 21, 2025	$0.2000
Nov 22, 2024	$0.2000
Aug 23, 2024	$0.2000
Jun 7, 2024	$0.2000
Feb 22, 2024	$0.2000
Nov 16, 2023	$0.2000
Aug 17, 2023	$0.2000
Jun 1, 2023	$0.2000
Feb 16, 2023	$0.2000
Nov 17, 2022	$0.2000
Aug 18, 2022	$0.2000
Jun 2, 2022	$0.2000
Feb 17, 2022	$0.2000
Nov 18, 2021	$0.1500
Aug 19, 2021	$0.1500
Jun 3, 2021	$0.1213
Feb 20, 2020	$0.2425
Nov 21, 2019	$0.2425
Aug 22, 2019	$0.2425
May 30, 2019	$0.2425

Cells marked with a small ◇ are sourced from SEC's bulk Financial Statement Data Sets, which can lose dimensional context (notably Revenue and Operating Income for issuers that report by segment). These cells will be replaced with authoritative values from the Company Facts API as the backfill completes.